Abstract 696: Reduced-Dose Statin Therapy Complemented With Nutraceuticals Alters HDL Proteomics

We have previously shown that for patients who are “good responders” to nutraceuticals, statin dosage can be reduced by half, without change in biomarkers of CVD risk, provided that these specific ...